1. ScholarBank@NUS

Ross Andrew Soo

rp03556

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
Main Affiliation
 
Faculty
 
Email
csiras@nus.edu.sg
 

Publications

Results 21-40 of 91 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
212018Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samplesSoo, R.A ; Lim, J.S.Y ; Asuncion, B.R ; Fazreen, Z; Herrera, M.C; Omar, M.F.M; Phuong, N.H.D; Seet, J.E ; Amanuel, B; Iacopetta, B; Byrne, D; Hendry, S; Fox, S; Soong, R 
2Apr-2012Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapySoo, R.A. ; Kawaguchi, T.; Loh, M. ; Ou, S.-H.I.; Shieh, M.P.; Cho, B.-C.; Mok, T.S.; Soong, R. 
313-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
42018Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapyLimviphuvadh, V; Tan, C.S; Konishi, F; Jenjaroenpun, P; Xiang, J.S; Kremenska, Y; Mu, Y.S; Syn, N; Lee, S.C; Soo, R.A ; Eisenhaber, F ; Maurer-Stroh, S ; Yong, W.P 
51-Feb-2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangementKim, H.R.; Shim, H.S.; Chung, J.-H.; Lee, Y.J.; Hong, Y.K.; Rha, S.Y.; Kim, S.H.; Ha, S.-J.; Kim, S.K.; Chung, K.Y.; Soo, R. ; Kim, J.H.; Cho, B.C.
6Dec-2008Does saturable formation of gemcitabine triphosphate occur in patients?Tham, L.-S.; Wang, L.-Z. ; Soo, R.A. ; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.; Holford, N.H.G.
72018Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerTsui, D.W.Y; Murtaza, M; Wong, A.S.C ; Rueda, O.M; Smith, C.G; Chandrananda, D; Soo, R.A ; Lim, H.L; Goh, B.C ; Caldas, C; Forshew, T; Gale, D; Liu, W; Morris, J; Marass, F; Eisen, T; Chin, T.M ; Rosenfeld, N
82016EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: A retrospective database analysis of potential drug interactionKumarakulasinghe, N.B; Syn, N; Soon, Y.Y; Asmat, A; Zheng, H; Loy, E.Y; Pang, B ; Soo, R.A 
917-Jun-2020Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and MouseVerma, Riva ; Er, Jun Zhi ; Pu, Ren Wei; Mohamed, Jameelah Sheik ; Soo, Ross A ; Muthiah, Harish Mithiran; Tam, John Kit Chung ; Ding, Jeak Ling 
10Jun-2011Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: Results of a meta-analysis of randomized controlled trialsSoo, R.A. ; Loh, M. ; Mok, T.S.; Ou, S.-H.I.; Cho, B.-C.; Yeo, W.-L. ; Tenen, D.G.; Soong, R. 
11Apr-2008Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancerWong, A.S.; Soong, R. ; Seah, S.B.-K.; Lim, S.-W. ; Chuah, K.-L.; Nga, M.-E.; Chin, T.-M. ; Soo, R.A. 
12Sep-2022Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLCHuang, Y; Zhao, JJ; Soon, YY; Kee, A; Tay, SH; Aminkeng, F ; Ang, Y; Wong, A; Goh, BC; Soo, R 
1312-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
141-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
152018Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancerAli, A ; Levantini, E; Teo, J.T ; Goggi, J ; Clohessy, J.G; Wu, C.S ; Chen, L ; Yang, H ; Krishnan, I; Kocher, O; Zhang, J; Soo, R.A ; Bhakoo, K ; Chin, T.M ; Tenen, D.G 
25620-Feb-2013Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancerKim, H.R.; Kim, D.J.; Kang, D.R.; Lee, J.G.; Lim, S.M.; Lee, C.Y.; Rha, S.Y.; Bae, M.K.; Lee, Y.J.; Kim, S.H.; Ha, S.-J.; Soo, R.A. ; Chung, K.Y.; Kim, J.H.; Lee, J.H.; Shim, H.S.; Cho, B.C.
257Nov-2009First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Soo, R.A. ; Anderson, B.O.; Cho, B.C.; Yang, C.-H.; Liao, M.; Lim, W.-T.; Goldstraw, P.; Mok, T.S.
25820-Jan-2012Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesisZhang, W.C.; Ng, S.-C.; Yang, H.; Rai, A.; Umashankar, S.; Ma, S.; Soh, B.S.; Sun, L.L.; Tai, B.C. ; Nga, M.E.; Bhakoo, K.K.; Jayapal, S.R.; Nichane, M.; Yu, Q.; Ahmed, D.A.; Tan, C.; Sing, W.P.; Tam, J.; Thirugananam, A.; Noghabi, M.S.; Pang, Y.H.; Ang, H.S.; Robson, P.; Kaldis, P.; Soo, R.A. ; Swarup, S. ; Lim, E.H.; Lim, B.
259May-2011How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?Wong, A.S.; Seto, K.-Y.; Ang, B.; Wong, E.; Chin, T.-M. ; Nga, M.-E.; Soo, R.A. 
2607-Oct-2011INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerWu, Y.-L.; Park, K.; Soo, R.A. ; Sun, Y.; Tyroller, K.; Wages, D.; Ely, G.; Yang, J.C.-H..; Mok, T.